cyclopentenone has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiaro, C; Gandhi, UH; Hafer, KT; Hankey, P; Hegde, S; Kaushal, N; Kennett, MJ; Paulson, RF; Prabhu, KS; Ravindra, KC; Thompson, JT; van den Heuvel, JP | 1 |
1 other study(ies) available for cyclopentenone and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Survival; Cyclopentanes; DNA-Binding Proteins; Dose-Response Relationship, Drug; Fatty Acids, Omega-3; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Structure; Neoplastic Stem Cells; Prostaglandins; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Splenomegaly; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2011 |